特朗普宣布医药产品征收200%关税，中国金龙指数逆势涨超2%

Group 1 - The U.S. government announced a significant trade policy adjustment, imposing tariffs of up to 200% on pharmaceutical products and considering a 50% additional tax on imported copper [1][3] - Companies will have approximately one to one and a half years to adjust to these new tariffs, which primarily target the pharmaceutical sector's reliance on imports [3] - The announcement led to a surge in U.S. copper prices, which spiked over 10%, reaching historical highs in the New York market, reflecting investor concerns about supply chain restructuring [3] Group 2 - In contrast to global market declines, Chinese assets showed strong performance, with the Nasdaq Golden Dragon China Index rising over 2% [4] - Notable gains were observed in various Chinese tech and consumer stocks, with companies like Cloud Mi Technology surging over 53%, and others like iQIYI and Bilibili increasing by over 7% [4] - The strong performance of these companies indicates investor confidence in the Chinese technology and consumer sectors [4]